Tissue Engineered Veins in Patients With Chronic Venous Insufficiency
Status:
Not yet recruiting
Trial end date:
2023-10-30
Target enrollment:
Participant gender:
Summary
This study aims to evaluate the safety (incidence of adverse events including serious adverse
events and clinical significant laboratory abnormalities) of personalized tissue engineered
veins (P-TEV) with valves implanted in patients with severe chronic venous insufficiency
(CVI). For each patient a segment of the femoral vein containing the non-functioning valve
will be surgically replaced with a single P-TEV containing a functioning valve.